ERD

Sort by

European Partnerships

Show in overview

EU-Programme-Call

Show in overview

7 items found

Toggle all information

EJP RD | European Joint Programme on Rare Diseases

01-01-2019

31-08-2024

Show more information

Organisation Universitaetsklinikum Tuebingen

ChiLTERN | Children’s Liver Tumour European Research Network

01-01-2016

31-12-2021

Show more information

Organisation Universitaetsklinikum Tuebingen

PRONKJEWAIL | Protecting patients with enhanced susceptibility to infections

01-09-2016

31-08-2021

Show more information

Organisation Universitaetsklinikum Tuebingen

ALBINO | Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome

01-01-2016

30-06-2025

Show more information

Organisation Universitaetsklinikum Tuebingen

PROOF | Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial

01-01-2017

30-06-2023

Show more information

Organisation Universitaetsklinikum Tuebingen

TT4CL | Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

01-05-2019

31-07-2024

Show more information

Organisation Universitaetsklinikum Tuebingen

Prevent-nCoV | Prevention of SARS-CoV-2 infection through development and clinical testing of a novel Virus Like Particle (VLP) vaccine

01-04-2020

30-06-2022

Show more information

Organisation Universitaetsklinikum Tuebingen

Projects overview

Selected filters:

EJP RD | European Joint Programme on Rare Diseases

ChiLTERN | Children’s Liver Tumour European Research Network

PRONKJEWAIL | Protecting patients with enhanced susceptibility to infections

ALBINO | Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome

PROOF | Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial

TT4CL | Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Prevent-nCoV | Prevention of SARS-CoV-2 infection through development and clinical testing of a novel Virus Like Particle (VLP) vaccine